JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...

JMP Securities adjusted its price targets for two key players in the residential mortgage REIT industry. MFA Financial, Inc. (NYSE:MFA) saw its price target reduced to $12.50 from $13.50, while ...

JMP Securities analyst Steven DeLaney lowered the firm’s price target on Redwood Trust (RWT) to $8 from $9 and keeps an Outperform rating on ...

JMP Securities analyst Matthew Carletti reiterated a Hold rating on RLI (RLI – Research Report) today. The company’s shares closed yesterday at ...

Analysts at JMP Securities began coverage on shares of Trade Desk (NASDAQ:TTD – Get Free Report) in a note issued to ...

Orchid Island Capital Inc (ORC) stock saw a decline, ending the day at $7.94 which represents a decrease of $-0.08 or -1.00% from the prior close of $8.02. The stock opened at $8.01 and touched a low ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...

JMP Securities restated their market outperform rating on shares of Churchill Downs (NASDAQ:CHDN – Free Report) in a report ...

JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...

Benchmark believes that Roku can benefit meaningfully from establishing partnerships with other platforms and further ...

JMP Securities initiated coverage of Context Therapeutics (CNTX) with an Outperform rating and $4 price target Context is a $97.8M market cap clinical-stage biotechnology company focused on ...

JMP Securities analyst Silvan Tuerkcan initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $15 price target Solid is a clinical-stage biotechnology company focused on ...